TrialHuman vaccines & immunotherapeutics2018

A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.

Raches Ella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.